Luu M, Schütz B, Lauth M, Visekruna A (2023) The impact of gut microbiota-derived metabolites on the tumor immune microenvironment. Cancers 15:1588. doi: 10.3390/cancers15051588.
Koehler U, Hildebrandt O, Krönig J, Grimm W, Otto J, Hildebrandt W, Kinscherf R. Chronic hypoxia and cardiovascular risk: Clinical significance of different forms of hypoxia. Herz. 2017 May 4. doi: 10.1007/s00059-017-4570-5.
Kinscherf R (2011). Redox pioneer: Professor Wulf Dröge. Antioxid Redox Signal 14(11): 2319-23.
Bonaterra GA, Zügel S, Kinscherf R (2010). Novel systemic cardiovascular disease biomarkers. Curr Mol Med 10(2): 180-205.
Dröge W, Kinscherf R (2008). Aberrant insulin receptor signaling and amino acid homeostasisas a major cause of oxidative stress in aging. Antioxidants & Redox Signaling 10(4): 661-78.
Kinscherf R, Deigner HP (2008). Apoptogenic signal transduction in arteriosclerosis-associated cells – opportunities for future therapy? Vascular Disease Prevention 5 (2): 116-128.
Dröge W, Kinscherf R, Hildebrandt W, Schmitt T (2006). The deficit in low molecular weightthiols as a target for antiageing therapy. In: Deigner HP, Kinscherf R (guest eds.) Special Issue Current Drug Targets: "Ageing - upcoming opportunities for drug development". Curr Drug Targets 7(11):1505-1512.
Strüder H, Kinscherf R, Diserens K, Weicker H (2002). Physiologie und Pathophysiologie der Basalganglien: Einfluss auf die Motorik. Deutsche Zeitschrift Sportmed 52 (12): 350-361.
Weicker H, Kinscherf R, Diserens K, Deigner HP, Strüder HK (2001). Physiology and patho-physiology of basalganglia: impact on motor system function. Eur J Sports Sci 1(2): 1-46.
Claus R, Russwurm S, Meisner M, Kinscherf R*, Deigner HP* (2000). Modulation of theceramide level, a novel therapeutic concept? Curr Drug Targets 1(2): 185-205 *beide Verfasser teilen sich die Seniorautorenschaft.
Aumüller G, Wilhelm B, Seitz J (1999). Apocrine secretion: Fact or artifact. Annals Anatom 181: 437-446.
Deigner HP, Haberkorn U, Kinscherf R (2000). Apoptosis modulators in the therapy of neuro-degenerative diseases. Exp Opin Invest Drugs 9(4): 747-764.
Deigner HP, Kinscherf R (1999). Modulating apoptosis: Current applications and pro-spects for future drug development. Curr Med Chem 6: 399-414.
Meinhardt A, Wilhelm B, Seitz J (1999). Expression of mitochondrial marker proteins during the differentiation of male germ cells. Hum Reprod Update 5: 108-119.
Wilhelm B, Meinhardt A, Seitz J (1996). Transglutaminases: Purification and activity assays. J Chromatography B 684: 163-177.